Roham Zamanian

Clinical Focus

• Pulmonary Hypertension
• Pulmonology (Lung) and Critical Care
• Pulmonary Medicine

Administrative Appointments

• Clinical Director, VMWC Pulmonary Hypertension Database, Vera Moulton Wall Center for Pulmonary Vascular Disease (2006 - present)
• Director, Adult Pulmonary Hypertension Service, Vera Moulton Wall Center for Pulmonary Vascular Disease (2007 - present)

Honors and Awards

• Faculty Teaching Award, Dept of Medicine, Stanford (2007)
• Young Investigator Career Development Award, Entelligence Actelion Young Investigators Program (2006-2007)
• Fellow of the Year, Univ of Califronia, Irvine Medical Center (2002-2003)
• Resident Research Presentation Award, Univ of Calif, Irvine Medical Center - Dept of Medicine (2001)
• Case Presentation Award, ACCP - Chest 2000 (2000)

Professional Education

Postdoctoral Advisees

David Poch

Web Site Links

• Wall Center for Pulmonary Vascular Disease

Research Interests

1. The Utility of S100A4/Mts1 as a Biomarker in Pulmonary Arterial Hypertension (PAH).

2. Prevalence and Treatment of Insulin Resistance in PAH.

3. The Effect of EGF-Receptor Blockade and Elastase Inhibitor on Pulmonary Arteries of Patients with PAH.

4. Characterization of Pulmonary Arteries in Patients with Idiopathic and Secondary PAH by Wedge Angiography.

5. The Optimal Angle for Angiographic Evaluation of the Left Pulmonary Artery in Patients with PAH.

Clinical Trials

• Insulin Resistance in Pulmonary Arterial Hypertension Recruiting

Publications

• A novel non-invasive method of estimating pulmonary vascular resistance in patients with pulmonary arterial hypertension. Haddad F, Zamanian R, Beraud AS, Schnittger I, Feinstein J, Peterson T, Yang P, Doyle R, Rosenthal D. J Am Soc Echocardiogr. 2009; 22 (5): 523-9
• Plasma levels of S100A4 in portopulmonary hypertension. Peng T, Zamanian R, Krowka MJ, Benza RL, Roberts KE, Taichman DB, Rybak D, Trotter JF, Brown RS, Fallon MB, Kawut SM. Biomarkers. 2009; 14 (3): 156-60
• Insulin resistance in pulmonary arterial hypertension. Zamanian RT, Hansmann G, Snook S, Lilienfeld D, Rappaport KM, Reaven GM, Rabinovitch M, Doyle RL. Eur Respir J. 2009; 33 (2): 318-24
• ERG evaluation of daily, high-dose sildenafil usage. Zoumalan CI, Zamanian RT, Doyle RL, Marmor MF. Doc Ophthalmol. 2009; 118 (3): 225-31
• Angina associated with left main coronary artery compression in pulmonary hypertension. de Jesus Perez VA, Haddad F, Vagelos RH, Fearon W, Feinstein J, Zamanian RT. J Heart Lung Transplant. 2009; 28 (5): 527-30